⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5609825 | 0.81 | — | — | |
| SCHEMBL4966817 | 0.77 | CA1 (0.30) | — | |
| SCHEMBL27707446 | 0.64 | — | — | |
| SCHEMBL8426450 | 0.62 | CA1 (0.30) | — | |
| SCHEMBL5164347 | 0.62 | — | — | |
| SCHEMBL2008832 | 0.62 | — | — | |
| SCHEMBL692809 | 0.57 | — | — | |
| SCHEMBL2016425 | 0.57 | — | — | |
| SCHEMBL6206932 | 0.56 | — | — | |
| SCHEMBL2728136 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3890715-A1 | THERAPEUTICS TARGETING MUTANT ADENOMATOUS POLYPOSIS COLI (APC) FOR THE TREATMENT OF CANCER | The Board Of Regents Of The University Of Texas System (US) | 2021-10-13 | — | — | EP | disclosed |
| WO-2020117972-A1 | THERAPEUTICS TARGETING MUTANT ADENOMATOUS POLYPOSIS COLI (APC) FOR THE TREATMENT OF CANCER | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-06-11 | — | — | WO | disclosed |
| EP-2632920-A1 | SULFONAMIDES FOR THE MODULATION OF PKM2 | Dynamix Pharmaceuticals Ltd. (IL) | 2013-09-04 | — | — | EP | disclosed |
| WO-2012056319-A1 | SULFONAMIDES FOR THE MODULATION OF PKM2 | DYNAMIX PHARMACEUTICALS LTD. (IL) | 2012-05-03 | — | — | WO | disclosed |